Costlier AMD Prescriptions Linked to Manufacturer Payments to Ophthalmologists
A cross-sectional analysis of Medicare Part B data spending shows ophthalmologists who received manufacturer funding were less likely to prescribe bevacizumab.
United States Sean Dickson Katelye James American Academy Of Ophthalmology Drug Administration American Academy
Source: hcplive.com